Seniors Had High Burden of RSV-Positive Respiratory Infection Before COVID-19
Following sharp decline during COVID-19, RSV-positive acute respiratory infection reemerged during summer 2021, and is linked to lower QOL
Diagnosis & Disease Information
MPR Weekly Dose Podcast #145
Pfizer-BioNTech bivalent vaccine under investigation; Trial evaluating HIV prevention vaccine discontinued; Early detection sepsis test cleared; Trial results for RSV-associated disease vaccine; Combo Tx for HCC recurrence shows promise.
Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults
Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.
December 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in December 2022 for investigational products in development.
Nirsevimab Under Review for Protection Against RSV for All Infants
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
US to Release Flu Meds From National Stockpile to Ease Shortages
Decision comes as the nation suffers from an unusually early and hard flu season, with about 9,300 deaths so far
In Face of Tripledemic, CVS and Walgreens Limit Purchases of Pediatric Pain Meds
Medication limits are meant to ‘ensure equitable access,’ according to a CVS statement
White House ‘Winter Preparedness Plan’ Revives Free At-Home COVID-19 Test Program
Every household in the country is eligible to receive four free COVID-19 nasal swab testing kits
Bivalent RSV Vaccine Candidate Gets Priority Review for Older Adults
The BLA is supported by data from the phase 3 RENOIR trial which included approximately 37,000 adults 60 years of age and older.
Feds Urge Vaccination as ‘Tripledemic’ Hits More Americans
Vaccination will be key to keeping patients healthy through the winter holidays
